Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 575,795,264
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 33,724 M
  • Annual Income, $ 12,151 M
  • 60-Month Beta 0.41
  • Price/Sales 16.89
  • Price/Cash Flow 42.13
  • Price/Book 36.79
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 35.34% ( -0.65%)
  • Historical Volatility 18.22%
  • IV Percentile 83%
  • IV Rank 57.41%
  • IV High 44.88% on 08/03/23
  • IV Low 22.48% on 06/13/23
  • Put/Call Vol Ratio 0.35
  • Today's Volume 33,290
  • Volume Avg (30-Day) 19,713
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 269,251
  • Open Int (30-Day) 268,157

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.77
  • Number of Estimates 3
  • High Estimate 0.79
  • Low Estimate 0.74
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
121.79 +6.09%
on 04/16/24
130.46 -0.96%
on 04/30/24
+1.66 (+1.30%)
since 04/01/24
3-Month
113.24 +14.10%
on 02/02/24
138.28 -6.56%
on 03/07/24
+13.42 (+11.59%)
since 02/01/24
52-Week
75.56 +71.00%
on 07/11/23
138.28 -6.56%
on 03/07/24
+45.50 (+54.35%)
since 05/01/23

Most Recent Stories

More News
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.

We also look at the "treasure hunt" economy.

TSM : 134.94 (-1.75%)
WMT : 58.85 (-0.84%)
TGT : 156.43 (-2.83%)
DIS : 110.48 (-0.56%)
LLY : 776.75 (-0.56%)
AXP : 231.46 (-1.10%)
COF : 141.64 (-1.25%)
SPG : 140.18 (-0.25%)
NVO : 129.21 (+0.70%)
TJX : 93.82 (-0.29%)
DG : 137.58 (-1.16%)
ALLY : 38.56 (+0.55%)
Eli Lilly Raises Sales Forecast as Demand for Weight-Loss Drug Surges

Eli Lilly (LLY) has boosted its 2024 sales forecast by $2 billion, fueled by unprecedented demand for its innovative weight-loss drug, Zepbound, along with its diabetes treatment, Mounjaro. The surge in...

LLY : 776.75 (-0.56%)
TSLA : 179.99 (-1.80%)
WMT : 58.85 (-0.84%)
NVO : 129.21 (+0.70%)
Here's Why Novo Nordisk Stock Is a Buy Right Now

Novo Nordisk stock has surged, outperforming the market this year. Here's why it still looks like a buy right now.

NVO : 129.21 (+0.70%)
$SPX : 5,018.39 (-0.34%)
LLY : 776.75 (-0.56%)
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks

The "Magnificent Seven" stocks dominate the artificial intelligence (AI) arena. One notable hedge fund manager has three in his top 10 holdings.

MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
TSLA : 179.99 (-1.80%)
INTC : 30.37 (-0.33%)
GOOG : 165.57 (+0.56%)
NVO : 129.21 (+0.70%)
NVDA : 830.41 (-3.89%)
META : 439.19 (+2.10%)
AMZN : 179.00 (+2.29%)
Is Viking Therapeutics Incredibly Undervalued?

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

PFE : 27.18 (+6.09%)
VKTX : 76.43 (-3.96%)
LLY : 776.75 (-0.56%)
NVO : 129.21 (+0.70%)
Forget Nvidia, These Unstoppable Stocks Are Better Buys

These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence.

NVDA : 830.41 (-3.89%)
LLY : 776.75 (-0.56%)
NVO : 129.21 (+0.70%)
UNH : 484.11 (+0.08%)
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On

Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.

NVO : 129.21 (+0.70%)
JPM : 191.86 (+0.06%)
LLY : 776.75 (-0.56%)
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market

Lilly recently announced news that could solve a big problem.

NVO : 129.21 (+0.70%)
GS : 426.95 (+0.06%)
LLY : 776.75 (-0.56%)
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

CRSP : 53.81 (+1.55%)
LLY : 776.75 (-0.56%)
NVO : 129.21 (+0.70%)
VRTX : 402.14 (+2.38%)
VKTX : 76.43 (-3.96%)
Better Buy: Pfizer vs. Viking Therapeutics

These two pharma stocks have followed distinct paths of late. Which is the better investment?

LLY : 776.75 (-0.56%)
NVO : 129.21 (+0.70%)
NVDA : 830.41 (-3.89%)
AMGN : 277.37 (+1.25%)
PFE : 27.18 (+6.09%)
VKTX : 76.43 (-3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 133.02
2nd Resistance Point 131.58
1st Resistance Point 130.39
Last Price 129.21
1st Support Level 127.76
2nd Support Level 126.32
3rd Support Level 125.13

See More

52-Week High 138.28
Last Price 129.21
Fibonacci 61.8% 114.32
Fibonacci 50% 106.92
Fibonacci 38.2% 99.52
52-Week Low 75.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar